Mortality audit of the Finnish cervical cancer screening program

International Journal of Cancer

Volumn 132, Issue 9, 2013, Pages 2134-2140

  Lönnberg, Stefan ^a   Nieminen, Pekka ^b   Luostarinen, Tapio ^a   Anttila, Ahti ^a  

^a FINNISH CANCER REGISTRY   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

audit; case control studies; mass screening; mortality; uterine cervical neoplasms

Indexed keywords

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CASE CONTROL STUDY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC VALUE; ETHNIC GROUP; FEMALE; FINNISH; HUMAN; MAJOR CLINICAL STUDY; MEDICAL AUDIT; PRIORITY JOURNAL; RISK REDUCTION; UTERINE CERVIX CARCINOMA; UTERUS CARCINOMA;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; MEDICAL AUDIT; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 84874117644     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27844     Document Type: Article

References (17)

1. IARC. IARC handbooks of cancer prevention: cervix cancer screening, vol. 10. Lyon: IARC Press, 2005. 302.
2. Lönnberg S, Anttila A, Luostarinen T, Nieminen P,. Age-specific effectiveness of the Finnish cervical cancer screening programme. Cancer Epidemiol Biomarkers Prev 2012; 23: 172-80.
3. Sasieni P, Castanon A, Cuzick J,. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. Br Med J 2009; 339: b2968.
4. Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S,. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008; 100: 622-9.
5. Anttila A, Hakama M, Kotaniemi-Talonen L, Nieminen P,. Alternative technologies in cervical cancer screening: a randomized evaluation trial. BMC Public Health 2006; 6: 252.
6. Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A,. Age-specific evaluation of primary human papillomavirus screening vs. conventional cytology in a randomized setting. J Natl Cancer Inst 2009; 101: 1612-23.
7. van der Aa MA, Pukkala E, Coebergh JW, Anttila A, Siesling S,. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. Int J Cancer 2008; 122: 1854-8.
8. Anttila A, Nieminen P,. Cervical cancer screening programme in Finland with an example on implementing alternative screening methods. Coll Antropol 2007; 31 (Suppl 2): 17-22.
9. Andrae B, Andersson TM, Lambert PC, Kemetli L, Silfverdal L, Strander B, Ryd W, Dillner J, Tornberg S, Sparen P,. Screening and cervical cancer cure: population based cohort study. Br Med J 2012; 344: e900.
10. Duffy SW, Cuzick J, Tabar L, Vitak B, Chen TH-H, Yen M-F, Smith RA,. Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. J R Stat Soc Ser C 2002; 51: 235-43.
11. Sasieni P, Adams J, Cuzick J,. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003; 89: 88-93.
12. Engholm G, Ferlay J, Christensen N, Johannesen TB, Klint Å, Køtlum JE, Milter MC, Ólafsdõttir E, Pukkala E, Storm HH,. NORDCAN: cancer incidence, mortality, prevalence and survival in the nordic countries, Version 5.1 (March 2012): association of the nordic cancer registries. Danish Cancer Society.
13. Zappa M, Visioli CB, Ciatto S, Iossa A, Paci E, Sasieni P,. Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence. Br J Cancer 2004; 90: 1784-6.
14. Sasieni P, Castanon A, Cuzick J,. Screening and adenocarcinoma of the cervix. Int J Cancer 2009; 125: 525-9.
15. Weiss NS,. Case-control studies of the efficacy of screening tests designed to prevent the incidence of cancer. Am J Epidemiol 1999; 149: 1-4.
16. Terveyden ja hyvinvoinnin laitos. Terveyden ja hyvinvoinnin laitoksen asettaman papilloomavirustautien torjuntatyöryhmän selvitys [Report of the study by the Expert Group on Papillomavirus Disease Prevention appointed by the National Institute for Health and Welfare]. Available at: http://www.thl.fi/thl-client/pdfs/94d6f45d-22e1-4b53-b615-2eea48d90e1c.
17. Nieminen P, Kallio M, Anttila A, Hakama M,. Organized vs. spontaneous Pap-smear screening for cervical cancer: a case-control study. Int J Cancer 1999; 83: 55-8.